David H. Aggen

Single-cell protein activity analysis identifies recurrence-associated renal tumor macrophages

Aleksandar Obradović, Nivedita Chowdhury, Scott M. Haake et al. · Cell · 2021 · 354 citations · Full text

Medicine, Immunology, Single-cell Analysis +3

Phase II Trial of Cabozantinib Plus Nivolumab in Patients With Non–Clear-Cell Renal Cell Carcinoma and Genomic Correlates

Chung‐Han Lee, Martin H. Voss, Maria I. Carlo et al. · Journal of Clinical Oncology · 2022 · 182 citations · Full text

Blocking IL1 Beta Promotes Tumor Regression and Remodeling of the Myeloid Compartment in a Renal Cell Carcinoma Model: Multidimensional Analyses

David H. Aggen, Casey R. Ager, Aleksandar Obradović et al. · Clinical Cancer Research · 2020 · 118 citations · Full text

Bismuth compounds in organic synthesis. Bismuth nitrate catalyzed chemoselective synthesis of acylals from aromatic aldehydes

David H. Aggen, Joshua N. Arnold, Patrick D. Hayes et al. · Tetrahedron · 2004 · 112 citations

Chemical Engineering, Aromatic Aldehydes, Engineering +6

A sensitivity scale for targeting T cells with chimeric antigen receptors (CARs) and bispecific T-cell Engagers (BiTEs)

Jennifer D. Stone, David H. Aggen, Andrea Schietinger et al. · OncoImmunology · 2012 · 95 citations · Full text

Adaptive Immune System, Immunology, Immunoediting +18